Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02669173 |
Title | Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Case Comprehensive Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |